Alzheimer's disease biomarkers are crucial indicators used to detect and monitor the progression of Alzheimer's disease and dementia. These biomarkers include amyloid-beta and tau proteins, which accumulate abnormally in the brain, leading to cognitive decline and memory loss characteristic of the disease. Imaging techniques like PET scans can visualize amyloid plaques, while cerebrospinal fluid tests measure levels of amyloid-beta and tau proteins directly. Biomarkers play a pivotal role in early diagnosis, allowing for interventions to potentially slow disease progression and improve patient outcomes. Ongoing research focuses on refining these biomarkers to enhance accuracy and reliability in diagnosing Alzheimer's disease at its earliest stages, offering hope for better management and treatment strategies in the future.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States